0001193125-21-282451 Sample Contracts

4D MOLECULAR THERAPEUTICS, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT

Change in Control and Severance Agreement • September 24th, 2021 • 4D Molecular Therapeutics Inc. • Biological products, (no disgnostic substances) • California

• Contract Type
  Change in Control and Severance Agreement
• Filed
  September 24th, 2021
• Company
  4D Molecular Therapeutics Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  California

This Change in Control and Severance Agreement (the “Agreement”) is made and entered into by and between David Kirn, M.D. (“Executive”) and 4D Molecular Therapeutics, Inc. (the “Company”), effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).